Marker Therapeutics, Inc. 8-K

What Happened
Marker Therapeutics, Inc. (MRKR) announced on March 18, 2026 that it reported its financial results for the year ended December 31, 2025 and provided other recent corporate updates. The company furnished a press release describing those results as Exhibit 99.1 to the Form 8-K filed March 19, 2026.

Key Details

• Report date: March 18, 2026; Form 8-K filed March 19, 2026.
• Reporting period: financial results for the year ended December 31, 2025.
• Press release documenting the results is attached as Exhibit 99.1 to the 8-K.
• Cover Page interactive XBRL (Inline XBRL) file included as Exhibit 104.

Why It Matters
Annual financial results provide information that can affect investor decisions about company performance, outlook, and valuation. The 8-K indicates Marker has publicly released its 2025 results and related corporate updates; investors should review the furnished press release (Exhibit 99.1) for the specific revenue, expense, net loss/profit, cash position, and management commentary needed to assess impacts on the stock.